| SC 13G/A | 2024-02-13 | GIC Private Ltd | I-Mab | 4 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-09 | Zang Jingwu Zhang | I-Mab | 10,454,937 | 5.6% | EDGAR |
| SC 13D | 2023-12-01 | T Investment Ltd | I-Mab | 8,172,022 | 9.9% | EDGAR |
| SC 13D/A | 2023-06-30 | HHLR ADVISORS, LTD. | I-Mab | 15,891,211 | 8.3% | EDGAR |
| SC 13G/A | 2023-02-15 | CBC Investment I-Mab Ltd | I-Mab | 3,641,554 | 1.9% | EDGAR |
| SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | I-Mab | 281 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-08 | Zang Jingwu Zhang | I-Mab | 10,155,292 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-07 | GIC Private Ltd | I-Mab | 12,131,203 | 6.3% | EDGAR |
| SC 13G | 2022-06-13 | Infini Master Fund | I-Mab | 5,004,206 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-14 | GIC Private Ltd | I-Mab | 10,832,501 | 5.9% | EDGAR |
| SC 13G | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | I-Mab | 7,348,772 | 9.4% | EDGAR |
| SC 13G/A | 2022-02-11 | Zang Jingwu Zhang | I-Mab | 9,565,570 | 5.0% | EDGAR |
| SC 13G/A | 2022-01-25 | CBC Investment I-Mab Ltd | I-Mab | 3,641,554 | 2.0% | EDGAR |
| SC 13D/A | 2021-09-27 | HHLR ADVISORS, LTD. | I-Mab | 16,520,560 | 9.3% | EDGAR |
| SC 13G | 2021-07-19 | Fortune Eight Jogging Ltd | I-Mab | 8,301,555 | 4.7% | EDGAR |
| SC 13D/A | 2021-06-24 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 19,050,560 | 11.3% | EDGAR |
| SC 13G/A | 2021-06-21 | Genexine Inc. | I-Mab | 8,488,885 | 5.0% | EDGAR |
| SC 13D/A | 2021-03-25 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 19,050,560 | 11.3% | EDGAR |
| SC 13G | 2021-02-16 | Tasly Biopharmaceuticals Co., Ltd. | I-Mab | 13,655,240 | 8.3% | EDGAR |
| SC 13G | 2021-02-16 | Genexine Inc. | I-Mab | - | - | EDGAR |